A detailed history of Cambridge Investment Research Advisors, Inc. transactions in American Centy ETF Tr Avantis stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 4,242 shares of AVIV stock, worth $226,225. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,242
Previous 4,552 6.81%
Holding current value
$226,225
Previous $239,000 0.42%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$50.37 - $56.43 $15,614 - $17,493
-310 Reduced 6.81%
4,242 $238,000
Q2 2024

Jul 26, 2024

BUY
$52.26 - $55.37 $418 - $442
8 Added 0.18%
4,552 $239,000
Q1 2024

Apr 24, 2024

SELL
$49.42 - $54.08 $44,478 - $48,672
-900 Reduced 16.53%
4,544 $246,000
Q4 2023

Feb 09, 2024

BUY
$45.8 - $51.67 $274 - $310
6 Added 0.11%
5,444 $280,000
Q3 2023

Oct 24, 2023

SELL
$47.37 - $50.8 $7.24 Million - $7.76 Million
-152,754 Reduced 96.56%
5,438 $262,000
Q2 2023

Jul 13, 2023

BUY
$46.67 - $50.33 $1.75 Million - $1.89 Million
37,563 Added 31.14%
158,192 $7.69 Million
Q1 2023

May 11, 2023

BUY
$45.01 - $49.82 $795,551 - $880,568
17,675 Added 17.17%
120,629 $5.81 Million
Q4 2022

Feb 08, 2023

BUY
$38.26 - $46.54 $3.94 Million - $4.79 Million
102,954 New
102,954 $4.64 Million

Others Institutions Holding AVIV

About AMERICAN CENTY ETF TR AVANTIS


  • Ticker AVIV
More about AVIV
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.